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Abstract 
Background: Otitis media with effusion (OME) causes significant morbidity in children, but the causes of OME and 
methods for prevention are unclear. To look for potential infectious etiologies, we performed a pilot study using 
multiple‑target real‑time polymerase chain reaction (qPCR) for 27 infectious agents, including nine bacterial organ‑
isms and 18 respiratory viruses in middle ear fluids (MEFs) from children with OME. QPCR was also performed for the 
13 Streptococcus pneumoniae serotypes contained in the current vaccine.
Results: Forty‑eight MEF samples were obtained and qPCR detected bacterial nucleic acid (NA) in 39/48 (81 %) and 
viral NA in 7/48 (15 %). Alloiococcus otitidis and S. pneumoniae were both detected in 15/48 (31 %) MEFs, followed by 
M. catarrhalis in 14/48 (29 %), H. influenzae in 5/48 (10 %) and M. pneumoniae in 4/48 (8 %). Rhinoviruses were most 
common virus type detected, found in 4/48 (8 %) MEFs. Serotypes included in the current 13‑serotype vaccine were 
detected in only 3/15 (20 %) S. pneumoniae qPCR‑positive MEFs.
Conclusions: Bacteria may play an important role in OME, since over 80 % of MEFs contained bacterial NA. Further 
research into the role of A. otitidis in OME will be helpful. Serotypes of S. pneumoniae not included in the current 
13‑serotype vaccine may be involved in OME. Larger studies of OME S. pneumoniae serotypes are needed to help 
determine which additional serotypes should be included in future vaccine formulations in order to try to prevent 
OME.
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Background
Otitis media with effusion (OME) is a common child-
hood condition in which fluid persists in the middle ear 
cavity for 3 months or more. It has been estimated that 
up to 80  % of children have been affected by OME at 
some time by the age of four [1]. Many children suffering 
from this condition will have a mild to moderate hearing 
loss, averaging 27 decibels, which is sufficient to lead to 
language development delay [2].
While the exact pathogenesis of OME remains 
unknown, multiple hypotheses have been put forward. 
The position and length of the Eustachian tube in chil-
dren and a persistent inflammatory process in the middle 
ear cavity due to frequent upper respiratory tract infec-
tions are both thought to contribute to the frequency of 
OME in childhood [1].
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Since bacterial cultures of middle ear fluid (MEF) are 
negative in the majority of children with OME, OME was 
once thought to be an inflammatory but non-infectious 
condition. However, with the use of more sensitive molec-
ular detection methods such as polymerase-chain reaction 
(PCR), studies have shown that many bacterial culture-
negative OME specimens contain bacterial DNA [3–6].
Based on studies by Hall-Stoodley and others [7], it is 
now thought that bacteria persist chronically in the mid-
dle ear in the form of biofilms in many or most children 
with OME. Biofilms are known to be difficult to eradicate 
with antimicrobial therapy, which could account for the 
persistence of effusions in children treated with antibiotics 
for OME in clinical trials [8]. The biofilm hypothesis would 
also fit with the observation that bacterial cultures of MEF 
are often negative, as bacteria in biofilms are more difficult 
to culture than free-floating (planktonic) bacteria [8, 9].
Bacteria detected by molecular methods from OME 
middle ear fluid include those known to cause acute oti-
tis media (AOM), namely, Streptococcus pneumoniae, 
Haemophilus influenzae and Moraxella catarrhalis [3–
6]. As well as accepted otitis pathogens, other bacteria 
whose pathogenicity is the middle ear is uncertain, such 
as Alloiococcus otitidis and Helicobacter pylori have also 
been detected by molecular studies in OME samples 
[10–13].
Viruses have also been detected in some MEF from 
OME. Viral RNA was detected in approximately 1/3 of 
MEF samples from children undergoing tympanostomy 
tube insertion [14, 15]. Viruses detected by PCR have 
included rhinoviruses, enteroviruses, respiratory syncyt-
ial virus (RSV), and human coronaviruses [14–16].
In order to determine the prevalence of bacterial and 
viral agents in children with OME in our region, we per-
formed a pilot study using real-time PCR (qPCR) for 
twenty-seven bacterial and viral pathogens in MEF sam-
ples. Also, for the first time to our knowledge, MEFs were 
also tested directly for the 13 serotypes contained in the 
conjugate pneumococcal vaccine (Prevnar 13, Pfizer) to 
assess the potential impact of the 13-serotype S. pneumo-
niae on OME associated with this bacterium [17]. Our 
overall objectives were to better understand the microbi-
ology of OME in children, and to determine if the current 




1. Presence or absence of the bacteria and viruses listed 
in Table  1 as determined by real-time PCR from 
OME fluids.
2. Comparison of PCR and culture results for bacterial 
detection from OME fluids.
3. For S. pneumoniae, qPCR-positive OME fluids, the 
results of PCR serotyping for the serotypes contained 
in the 13-serotype S. pneumoniae vaccine.
Study design
This was a prospective observational study performed 
from Oct. 2011 to Oct 2012 at the Children’s Hospital of 
Eastern Ontario, Ottawa, Ontario, Canada, a 165 bed ter-
tiary care hospital serving a catchment area 1.5 million. 
In the province of Ontario, a 7- serotype S. pneumoniae 
vaccine was introduced for in 2002 and a 13-serotype 
vaccine in Dec. 2010. Both were part of the routine pub-
licly funded immunization schedule for infants beginning 
at 2 months of age. Children also received infant immu-
nization against H. influenzae type B.
Ethics and subject recruitment
Ethics approval was obtained for the study from the hos-
pital Research Ethics Board. Parents of children seen at 
the pediatric otolaryngology clinic at the CHEO for treat-
ment of OME who were to undergo tympanostomy tube 
insertion were identified and invited to participate in the 
study by the treating otolaryngologist. Informed con-
sent was sought from parents or guardians who wished 
to participate to allow the MEF to be collected and sent 
for bacterial culture and PCR studies. Immunization sta-
tus, age and sex of the child were recorded from hospital 
records in a study form.
The inclusion criteria were patients under the age of 
18  years of age requiring ventilation tube insertion for 
OME for whom informed consent was obtained. Patients 
not meeting these age, diagnosis, and consent criteria 
were excluded. OME was defined as the presence of fluid 
in the middle ear without signs or symptoms of acute ear 
infection that was associated with a conductive hearing 
loss of at least 30 decibels in two consecutive frequencies.
Collection of MEFs
In patients who consented to participate in the study, the 
external auditory canal was cleaned by bathing the canal 
in 70  % isopropyl alcohol for 60  s. A myringotomy was 
then performed and middle ear fluid from each ear was 
suctioned into a Juhn Tym-Tap suction container. For 
each ear, the fluid obtained was then divided into two 
portions, with one portion sent for standard microbiol-
ogy analysis (culture) and the second portion stored at 
−80 °C until for PCR testing was performed.
Laboratory methods
Culture methods
OME fluids were processed using standard microbio-
logical methods [18]. Aliquots were plated on sheep 
blood, chocolate, and MacConkey agar under aerobic 
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conditions at 37 °C and examined daily for five days. An 
aliquot was inoculated into thioglycollate broth and ali-
quots were plated on anaerobic agar media and kept for 
5 days under strict anaerobic conditions; these were also 
checked daily after being left initially for 48 h. Bacteria 
were identified used standard laboratory methods [18]. 
We did not perform viral or Mycoplasma pneumoniae 
cultures.
Table 1 Real-time PCR assays for bacteria, viruses and Streptococcus pneumoniae serotypes
RSV Respiratory syncytial virus; PIV Parainfluenza virus; HMPV human metapneumovirus; SP S. pneumoniae
a  Probes contained an internal quencher and no minor groove binder. All other probes contained a minor groove binder and no internal quencher
b  Primers from published reference, probe this study
Target Forward primer Reverse primer Probe (all with MGB excepta) Ref.
S. pneumoniae acgcaatctagcagatga agca tcgtgcgttttaattccagct tgccgaaaacgcttgatacagggaga [19]
H. influenzae ggttaaatatgccgatggtgttg tgcatctttacgcacggtgta ttgtgtacactccgttggtaaaagaacttgcaca [19]
A. otitidis ctacgcatttcaccgctacac ggggaagaacacggatagga agtccgccagtttccaatgccgttccaa [10]b
H. pylori cgtggcaagcatgatccat gggtatgcacggttacgagttt tcaggaaacatcgcttcaatacccactta [27]
M. catarrhalis gtcaaacagctggaggtattgc gacatgatgctcacctgctcta atcgcaattgcaacttt [28]
C. pneumoniae cgcgaaggaccttacctgga gtatctgtccttgcggaaagct ctacagttgtcaaatacatgtc [20]
M. pneumoniae cgtggtgaagtgaaacatctcagtag gcaagccctacaacccctatcta atgataagtttggcctgttc [20]
B. pertussis catcaagcaccgctttaccc tgttgggagttctggtaggtgtg cttaccgcccacagac [20]
B. parapertussis gatatcaacgggtgacggatc gcctgcacgttgctcgat cagcaattggctgcagg [20]
SP serotype 1 cgtgcggtaattgaagctatga tgtggccccagcaactct cttgcccttgtatagggt [21]
SP serotype 3 ggtcagcagaaagtatgcattgg tcgtttatccagggtctgatga tattggatgtggtttatcgtgaag [21]
SP serotype 4 cggcaggcaaaccaattat catctcgttcgggactaaca caggagatgctaaaata [21]
SP serotype 5 ttacgggagtatcttatgtctttaatgg cagcattccagtagcctaaaactaga tctcagcaactctatttgg [21]
SP serotype 6A gctagagatggttccttcagttgat catactctagtgcaaactttgcaaaat ctggctcatgatagtt [21]
SP serotype 6B gctagagatggttccttcagttgat catactctagtgcaaactttgcaaaat actgtctcatgataatt [21]
SP serotype 7F/A aagcacagtgcgtgaacaat aaaatctccctgtcccttcc ctattccagaagaatctc [21]
SP serotype 9 V/A tggaatgggcaaagggtagta tcggttccccaagattttctc ttaatcatgctaacggctcat [21]
SP serotype 14 cgactgaaatgtcactaggagaagat aatacagtccatcaattactgcaatactc attcgtttgccaatacttga [21]
SP serotype 18C/B ccctgaaactagttgggaaca ttccaatcatcacccattaca aaagtcagatgttaaagactac [21]
SP serotype 19A gctgtgtttatgggggttgg agagacgtttaggctcatttgc atgcaaaatgctcacctag [21]
SP serotype 19F/B/C aattcggtatttatgggagttgg agagacgtttaggctcattagc atgcaaaagtcaaatttaga [21]
SP serotype 23F ctgggccaagatatttaaaagagagt aattccgcatcagagtatgcaa ttgctcttcgaaaaatgt [21]
RSV A ctcaatttcctcacttctccagtgt cttgattcctcggtgtacctctgt cattatgcctaggccagcag [20]
RSV B ttcctaacttctcaagtgtggtccta ctggtttcttggcgtacctctatac tcccattatgcctagacct [20]
Influenza A ccccctcaaagccgagat caagattggtcttgtctttagcca ccatgagagcctcaagat [20]
Influenza B aatacggtggattaaacaaaagcaa caggaggtctatatttggttccatt catattgggcaatttccta [20
HMPV A cacctgagtgatttatcatacaagca ttagcatacagaatttctccacacaa acaccctcatcattgc [20] MGB
HMPV B caagaacaaatgtgacattgctgat gaaaactgccgcacaacatttag aagctgacagccatct [20]
Rhinovirus caagtaatggacagggtgtgaagag ccaaagtagtcggtcccatcc tccggcccctgaat [20]
Enterovirus gcccctgaatgcggctaa ggaaacacggacacccaaagta tctgcagcggaacc [20]
Bocavirus ggcagaattcagccatactcaaa tctgggttagtgcaaaccatga ccacagtcatcagacact [20] MGB
Adenovirus ccacggtggggtttctaaactt cccagtggtcttacatgcacatc tgcaccagacccgg [20]
Coronavirus OC43 cgatgaggctattccgactaggt ccttcctgagccttcaatatagtaacc tccgcctggcacggt [20]
Coronavirus 229E ttccgacgtgctcgaacttt ccaacacggttgtgacagtga tcctgaggtcaatgca [20]
Coronavirus HKU1 gccttgcgaatgaatgtgct tgcatcaccactgctagtaccac ttgctattatgttaagcctg [20] MGB
Coronavirus NL63 ggaagcgtgttcctaccagaga agcaagctgtggaaaacctttg caaagcactgaataac [20]
PIV1 acagatgaaattttcaagtgctactttagt gcctcttttaatgccatattatcattaga atggtaataaatcgactcgct [20]
PIV 2 tgcatgttttataactactgatcttgctaa gttcgagcaaaatggattatggt actgtcttcaatggagatat [20]
PIV 3 tgctgttcgatgccaacaa attttatgctcctatctagtggaagaca ttgctcttgctcctca [20]
PIV 4 cctggagtcccatccaaagtaag tgagactgttattttaagtgcatctatacg tttgttgatcaagacaatac [20]
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QPCR methods
Nucleic acids (NA) were extracted from MEF using an 
automated extraction device (iPrep, Life Technologies, 
Carlsbad, California). The qPCR primers and probes used 
for bacteria viruses, and S. pneumoniae serotype detec-
tion are shown in Table 1. All assays used 5′ exonuclease 
probes labeled at the 5′end with fluorescein amidite and 
with a quencher at the 3′ end.
For A. otitidis, we used previously published PCR prim-
ers for this bacterium [5, 10] but designed a 5′exonucle-
ase probe for qPCR rather than using intercalating dye 
detection [10]. A commercial qPCR program (Allele ID, 
Premier Biosoft) was used to design the probe and speci-
ficity was checked using BLAST searches and by testing 
the assay against multiple reference strains of bacteria.
QPCR methods were performed as described previ-
ously [19, 20]. All probes were labeled with fluorescein 
amidite (FAM). Probes containing minor groove binders 
(MGB) were obtained from Life Technologies (Carlsbad, 
CA). All other probes were obtained from Integrated 
DNA Technologies (Coralville, IA) and contained a pro-
prietary internal quencher (ZEN quencher, IDT). Briefly, 
singleplex real-time 5′exonuclease qPCR assays were 
prepared in 20 µL volumes in 96-well qPCR plate. Posi-
tive and negative control (no template) was performed 
with each qPCR plate run. QPCR plates were covered 
with MicroAmp® Optical Adhesive Film (Life Tech-
nologies Carlsbad, CA) to prevent cross-contamination. 
QPCR was performed with a 96 well fast cycling block 
on a ViiA7 thermocyler (Life Technologies Inc.) using 40 
cycles of 2-temperature thermocyling (95  °C ×  3  s and 
60 °C × 30 s).
Only samples which were positive with the S. pneu-
moniae qPCR assay were further tested using published 
serotype-specific qPCR assays for the 13 serotypes con-
tained in the current conjugated vaccine (serotypes 1, 
3, 4, 5, 6A, 6B, 7F, 9 V, 14, 18C, 19A, 19F, and 23F) [21]. 
QPCR serotyping assays were performed as above, with 
the exception that longer cycling times were used (40 
cycles of 2-temperature thermocyling were used, with 
95 °C × 15 s and 60 °C × 60 s).
Results
Thirty-one children were enrolled in the study. One child 
was excluded as tympanostomy was performed for AOM 
rather than OME, leaving 30 that were evaluated. Forty-
eight MEF samples were obtained from these 30 chil-
dren. Sixteen children were female and 14 were male. The 
median age was 34  months with range 11–120  months. 
Twenty-seven of the 30 (90  %) children had received 
the original 7-serotype S. pneumoniae vaccine as part of 
routine infant immunization program, while three older 
children born prior to introduction of this vaccine had 
not. None had received the 13-serotype S. pneumoniae 
vaccine.
The number of MEF specimens in which bacterial and 
viral organisms NA were detected by qPCR, both alone 
and with other agents, is shown in Table 2. Overall, qPCR 
detected bacterial DNA in 39/48 (81 %) MEFs from 26/30 
(87 %) children and detected viral NA in 7/48 (15 %) MEF 
from 5/30 (17 %) children. A. otitidis and S. pneumoniae 
DNA were both detected by qPCR in 15/48 (31 %) MEF, 
with A. otitidis in 11/30 (37 %) children and S. pneumo-
niae in 10/33 (33 %) children. These were followed by M. 
catarrhalis DNA in 14/48 (29 %) MEF from 10/30 (33 %) 
children, H. influenzae DNA in 5/48 MEF (10  %) from 
4/30 (13  %) children, and M. pneumoniae DNA in 4/48 
(8 %) MEF from 2/30 (7 %) children. Among the viruses 
tested for, rhinovirus RNA was present in 4/48 (8  %) 
MEF, coronavirus OC43 RNA in 2/48 (4  %) MEF, and 
influenza B RNA in 1/48 (2 %) MEF.
Bacteria were grown in culture from 11/48 (23 %) MEF 
from 10/30 (33  %) children. M. catarrhalis was isolated 
from five MEF, H. influenzae from 3 MEF, and S. pneu-
moniae from 2 MEF. All culture positive samples for 
these three bacteria were also PCR-positive. One MEF 
grew Streptococcus pyogenes (group A streptococcus), 
a bacterium not included in the PCR testing. A. otitidis 
was not grown in culture, and no anaerobic bacteria were 
grown in culture.
With regard to detection of multiple organisms (detec-
tion of ≥ bacterial or viral NA in the same MEF), there 
were 28/48 (58 %) MEF with NA from a single organism 
detected, 6/48 (13  %) MEF with NA from 2 organisms 
detected and 6/48 (13 %) MEF with NA from 3 organisms 
detected, and 8/48 with no NA detected. Of note, 6/7 
Table 2 Bacterial and  viral nucleic acid detected by  qPCR 
from middle ear fluid (MEF) samples from children under-














S. pneumoniae 15 5 10
A. otitidis 15 6 9
M. catarrhalis 14 9 5
H. influenzae 5 4 1
M. pneumoniae 4 2 2




Influenza B virus 1 1 0
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(86 %) viral- NA positive samples also had bacterial DNA 
detected by qPCR.
Streptococcus pneumoniae serotyping by qPCR 
detected serotype 19A DNA in MEF in 3/15 (20  %) S. 
pneumoniae qPCR-positive specimens. All three samples 
with serotype 19A DNA detected from children who had 
received the 7 serotype vaccine. Tests for the other 12 
vaccine serotypes were negative.
Discussion
The finding that over 80  % of MEF samples from chil-
dren with OME contained bacterial DNA supports the 
idea that OME may be an infectious process. A. otiti-
dis DNA was frequently detected but the pathogenicity 
of this organism in OME is uncertain. Several studies 
have reported detecting A.  otitidis by PCR in MEF [10, 
11]. One report suggests this bacterium may be part of 
the normal flora of the external ear, and not a middle-ear 
pathogen [22]. However, other studies show A. otitidis 
can stimulate an inflammatory response, suggesting it 
may cause disease in the middle ear. For example, A. oti-
tidis elicited higher levels of inflammatory mediators 
than S. pneumoniae in a cell line model [23].
The fact that we did not isolate A. otitidis in culture is 
consistent with findings that this organism typically does 
not grow in culture using the methods standardly used 
in clinical microbiology laboratories. For example, in one 
study, A. otitidis was not grown from any MEFs but 35 % 
were PCR-positive [11]. Improved methods to culture 
this organism from MEFs are being sought [24].
As seen in other studies, S. pneumoniae, M. catarrhalis, 
and H. influenzae DNA were detected in a much higher 
proportion of MEF by PCR than culture [4–6]. This may 
be due to the greater sensitivity of PCR over culture, or 
could reflect that PCR detects both live and dead bacteria, 
while culture requires live bacteria. Similar to our find-
ings, Hendolin reported 84 % of MEF were PCR-positive 
for bacteria while 32  % were culture positive [5], while 
Park reported 36.7 % MEF were PCR-positive for bacte-
ria and 14 % of samples were positive by culture [6]. This 
common trend may reflect the greater sensitivity of PCR 
for detecting bacteria in biofilm-related infections [8].
Among the accepted bacterial pathogens, S. pneu-
moniae was detected more frequently by qPCR than H. 
influenzae or M. catarrhalis. Since S. pneumoniae could 
be cultured from only 2/15 (13 %) qPCR positive MEFs, 
culture-based detection of S. pneumoniae in OME may 
grossly underestimate the importance of this bacterium, 
and serotyping of positive culture samples may similarly 
provide very limited information. Molecular serotyping 
methods using qPCR or other techniques that are cul-
ture-independent thus may have be a better approach to 
determining which S. pneumoniae serotypes need to be 
included in future vaccines to help prevent OME. To our 
knowledge, this is the first study in which molecular sero-
typing for S. pneumoniae has been performed directly on 
MEFs from children with OME.
Serotype 19A was the only serotype of the 13 included 
in the latest S. pneumoniae vaccine that was detected in 
the MEF in this study. Serotype 19A was not included 
in the original 7-serotype vaccine, but is included in the 
13 serotype vaccine, so this vaccine may decrease otitis 
caused by this serotype. However, our finding that only 
a minority of samples contained a serotype included in 
the new vaccine is concerning, as it suggests that non-
vaccine serotypes are important in OME. In this pilot 
study, we were unable to perform qPCR serotyping for all 
of the approximately 90 S. pneumoniae serotypes, but we 
plan to test for a greater number of serotypes in subse-
quent studies to help determine which serotypes should 
be included in future vaccines.
The detection of M. pneumoniae PCR in several sam-
ples is also of interest. M. pneumoniae has been detected 
in OME before, but it appears to be infrequent cause. For 
example, Strogard reported that only 1/150 MEF was 
PCR positive for M. pneumoniae [25].
Helicobacter pylori, known as a cause of peptic ulcer 
disease, has also recently been reported into be present 
in MEFS of children with OME in several studies, In a 
study from Iran, 43 % MEFs and 25 % of adenoid samples 
from children undergoing myringotomy were positive for 
H. pylori [12]. Similarly, a study from Turkey reported 
detection of H. pylori in 47 % of MEFs from children with 
OME [13]. The absence of this organism in our samples 
may reflect geographic variability in H. pylori exposure in 
children.
In terms of viral agents, despite testing for a large num-
ber of respiratory viral agents, RNA from rhinoviruses, 
which are the major cause of the common cold, were the 
most frequently detected viruses in this study, and have 
also been detected in some other OME studies [14, 16]. 
Virus NA was detected in a much smaller proportion of 
MEF than bacteria and was often detected with bacterial 
DNA. This suggests that viruses may not be a common 
direct cause of OME. However, it is possible that viral 
infections of the upper respiratory tract could lead to 
Eustachian tube dysfunction, which could contribute to 
OME. Studies examining both nasopharyngeal and MEF 
samples for bacteria and viruses by qPCR may help clar-
ify the role of viruses as possible co-factors in OME.
There are some limitations to this study that should 
be noted. First, the number of MEF studied was small, 
although the sample number was similar to that used in 
other work in this area [4, 5, 11]. We considered this to 
be a pilot study to guide future research so we elected 
to extensively study a smaller number of samples with a 
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large number of PCR assays (27 microorganism assays 
and 13 serotype assays for S. pneumoniae) to guide us as 
to priorities for future OME research. Similarly, given the 
small number of S. pneumoniae qPCR-positive samples 
available for molecular serotyping, it is not possible to 
make definite conclusions regarding the distribution of 
serotypes. Nevertheless, the findings suggest that molec-
ular serotyping will provide much more information than 
traditional culture-based serotyping, and also that sero-
types other than those contained in the 13-valent vaccine 
will need to be tested for in future studies.
Second, as noted above, PCR-positive results can occur 
from live or dead bacterial or viral micro-organisms. 
However, for bacteria, Post and others have shown in an 
animal model that purified DNA and DNA from intact 
but non-viable bacteria do not persist in the middle ear. 
In contrast, DNA from live bacteria could be detected for 
3 weeks post-middle ear inoculation even when antibiotic 
treatment caused bacterial culture to become negative [9].
Additional work that supports the concept that bac-
terial DNA detected by PCR represents live organisms 
comes from the study by Rayner and others [26]. This 
group used reverse transcriptase-polymerase chain reac-
tion (RT-PCR) to determine if bacterial messenger RNA 
(mRNA) was present in pediatric OME samples that con-
tained bacterial DNA but were sterile by standard cul-
tural methods. Since bacterial mRNAs have a very short 
half-life of seconds to minutes, detection of bacteria-
specific mRNAs suggests metabolically active organisms 
are present. This group found that 29/29 H. influenzae 
PCR- positive samples were also positive for H. influen-
zae mRNA by RT-PCR, which suggests that viable, meta-
bolically active organisms were present in these samples.
With respect to the correlation between the detection 
of viral NA detection by PCR and the presence of live 
virus in patient samples, one study has shown that this 
appears to depend on the type of virus. The duration of 
viral shedding for influenza viruses was not significantly 
different when measured by culture and PCR (13 vs. 
14  days, respectively). However, for RSV and parainflu-
enza viruses shedding lasted significantly longer by PCR 
than by culture. Unfortunately, rhinoviruses, the most 
common viruses found in our study, were not examined 
in this report [29].
Finally, although we tested for a wide range of organ-
isms, there have been additional agents found in OME 
for which we did not perform PCR. For example, the 
anaerobic organism Fusobacterium nucleatum was found 
in 6/20 (30 %) OME samples using PCR in one study [30]. 
Although anaerobic bacterial cultures in our study were 
negative, it is possible that F. nucleatum or other anaero-
bic bacteria may have been detected had we used PCR for 
these organisms.
Conclusion
Bacterial infections may play a role in OME since over 
80  % of MEFS were qPCR-positive for bacterial organ-
isms, while viruses were found in a much smaller propor-
tion. Further studies to determine the pathogenicity of A. 
otitidis are needed. Additional S. pneumoniae serotypes 
not included in the 13-serotype vaccine may be important 
in OME, but this needs to be confirmed by larger studies.
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